Frequency and risks associated with Clostridium difficile‐associated diarrhea after pediatric solid organ transplantation: a single‐center retrospective review

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 18, Iss. 5, 2016-10 ,pp. : 706-713

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fidaxomicin versus Vancomycin as a First‐Line Treatment for Clostridium difficile–Associated Diarrhea in Specific Patient Populations: A Pharmacoeconomic Evaluation

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 37, Iss. 12, 2017-12 ,pp. : 1489-1497

John Wiley & Sons Inc

Access to resources Recommend Favorite

Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea

By Garborg Kjetil   Waagsbø Bjørn   Stallemo Asbjørn   Matre Jon   Sundøy Anders  

Scandinavian Journal of Infectious Diseases, Vol. 42, Iss. 11-12, 2010-12 ,pp. : 857-861

Informa Healthcare

Access to resources Recommend Favorite

Bacillus amyloliquefaciens as prophylactic treatment for Clostridium difficile‐associated disease in a mouse model

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 8, 2015-08 ,pp. : 1275-1280

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Clostridium difficile in Childhood Nosocomial Diarrhea

By Oĝuz Funda   Uysal Gülnar   Daşdemir Serap   Oskovi Hülya   Vidinlisan Sadi  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 10, 2001-10 ,pp. : 731-733

Informa Healthcare

Access to resources Recommend Favorite